PHA-543613

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

PHA-543613

Specification
Cat. No.
SMD1634
Related Diseases
Schizophrenia
Product Name
PHA-543613
Size
5.0mg; 25.0mg
Price
Inquiry
Availability
2 Weeks
Description
PHA-543613 acts as a potent and selective agonist for the α7 subtype of neural nicotinic acetylcholine receptors, with a high level of brain penetration and good oral bioavailability. It is under development as a possible treatment for cognitive deficits in schizophrenia.
CAS Number
478149-53-0
Chemical Formula
C15H17N3O2
Exact Mass
271.1321
Molecular Weight
271.32
Elemental Analysis
C, 66.40; H, 6.32; N, 15.49; O, 11.79
Synonym
PHA-543613; PHA 543613; PHA543613.
IUPAC/Chemical Name
(R)-N-(Quinuclidin-3-yl)furo(2,3-C)pyridine-5-carboxamide
InChi Key
IPKZCLGGYKRDES-ZDUSSCGKSA-N
InChi Code
InChI=1S/C15H17N3O2/c19-15(12-7-11-3-6-20-14(11)8-16-12)17-13-9-18-4-1-10(13)2-5-18/h3,6-8,10,13H,1-2,4-5,9H2,(H,17,19)/t13-/m0/s1
SMILES Code
O=C(C1=CC2=C(OC=C2)C=N1)N[C@H]3CN4CCC3CC4
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top